NEIL Bajpayee
Keine laufenden Positionen mehr
Karriereverlauf von NEIL Bajpayee
Ehemalige bekannte Positionen von NEIL Bajpayee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Kairos Venture Investments LLC
 Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Private Equity Investor | 01.04.2018 | 30.10.2020 |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Direktor/Vorstandsmitglied | 01.05.2019 | 30.10.2020 |
Ausbildung von NEIL Bajpayee
| The Pennsylvania State University | Undergraduate Degree |
| University of California | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Undergraduate Degree | 1 |
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Finance |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
- Börse
- Insiders
- NEIL Bajpayee
- Erfahrung
